The PAN 2.0 initiative is a comprehensive effort on the part of the Income Tax Department to revamp the cornerstone of India’s Permanent Account Number (PAN) and Tax Deduction and Collection Account Number (TAN) infrastructure. Estimated to have a budget of ₹1,440 crore, the project involves design, development, implementation, and long-term operation.
Winning this mandate would have positioned Protean in a strategic position to shape India’s tax-tech infrastructure for the years to come. Since PAN-related services contribute to almost half of Protean’s revenue, this tender wasn’t merely large — it was existential.
Yet, Protean revealed in an exchange filing that although it had tendered for the project as a Managed Service Provider, it was “not considered for the next stage” of assessment. Management further said that this would have “limited or minimal impact” on existing contracts, but the market apparently didn’t believe the hype.
Reason #1: Revenue Uncertainty Ahead
Brokerage Equirus indicated that PAN-related services account for around 50% of Protean’s revenue. Although the company retains an existing contract for PAN processing, the contract will be made redundant once PAN 2.0 is up and running.
Equirus estimates that Protean may experience a 75–100% reduction in PAN-associated revenues over the next two to three years. This would bring overall revenue down by 35% by FY27. Such a decline would strike not only topline figures, but also erode profitability and investor sentiment.
Reason #2: Decreasing Cash Flows and Stifled Growth Drivers
Free cash flow — once a sure source of financing for Protean’s growth — is now under threat. Disruption of future PAN business will substantially limit cash inflows that could otherwise have funded new projects.
Compounding this worry is the weak performance in other areas such as ONDC-connected retail data services. These areas are still to achieve significant scale and can’t fill in the impending revenue void immediately. In the absence of new wins or new mandates, Protean’s growth opportunities seem limited.
Reason #3: Sharp Downgrade and Target Price Cut
Investor sentiment took a further hit after Equirus downgraded Protean’s stock rating from “Add” to “Sell.” The brokerage also slashed its 12-month price target from ₹1,730 to just ₹900 — nearly a 48% cut. That sends a clear message: the street believes the risk-reward equation for Protean has shifted decisively toward caution.
For long-term shareholders, this downgrading is more than a fleeting adjustment. It reflects that the market views enduring difficulties on the horizon, particularly in restoring a revenue foundation and restoring competitive advantage in India’s rapidly changing government technology landscape.
Stock Performance Snapshot
The market panic was not unexpected. Protean’s stock had already lost 15% in the five days preceding the announcement. The 20% decline today puts the stock down 22% for the month — and 22% for the last six months, too. The steep descent is a reflection of investor dismay and more profound concerns about the long-term direction of the company.
What’s Next?
Though management has played down the significance of the PAN 2.0 miss, the street is viewing it as a serious strategic misstep. Protean needs to now quickly show traction elsewhere in its business verticals and convince investors of the sustainability of its profitability.
The stock is under pressure until then — and the journey from here is bound to be bumpy.
Authored by Oliviya Kunjumon
Published on May 19, 2025 | 10:50 IST
Follow us for more financial updates.
